About this episode
Send us an inquiry through a text message here! Welcome to another special episode of The Veterinary Roundtable! In this episode we're joined by the wonderful and amazing Dr. Ellen Ratcliff, VP of Clinical and Veterinary Medicine at Loyal, to dive deeper into how Loyal is studying longevity medicine in dogs and cats... and how one of their products could hit the market as soon as next year. We can't wait for you to listen to this episode! Do you have a question, story, or inquiry for The Veterinary Roundtable? Send us a text from the link above, ask us on any social media platform, or email theveterinaryroundtable@gmail.com! Episodes of The Veterinary Roundtable are on all podcast services along with video form on YouTube! Instagram: https://tinyurl.com/2h27xnfu TikTok: https://tinyurl.com/m8f62ame YouTube: https://tinyurl.com/48njfywd TIMESTAMPS Intro 00:00 Dr. Ratcliff's Military Background 02:35 How Dr. Ratcliff Found Loyal 07:58 An Overview Of Loyal 10:25 Loyal's Three Main Products 14:12 How LOY-002 Affects Metabolic Dysfunction 18:32 Are There Human Equivalents To Loyal's Products? 22:32 The Optimal Age For Dogs To Start Treatment 24:10 What Loyal Is Looking For During Their Clinical Trials 26:46 How Frailty Is Evaluated In Dogs 28:56 The Difference In Lifespan Between Intact vs Neutered/Spayed Pets 34:26 The Different Loyal Studies 36:14 How The Idea Of Loyal Came To Be 41:21 How Loyal Found Clinics For Their Studies 43:06 Are Loyal's Products Safe? 45:43 Purchasing LOY-002 Once It's Conditionally Approved 51:51 What's Next For Loyal? 55:16